Orchard Venture Partners is a US-based venture capital firm specializing in life sciences investments. The firm focuses on tangible scientific assets, typically investing in Series A, B, and C rounds. Their portfolio spans various stages of company development, from early-stage startups to more established enterprises.

Notable portfolio companies include Akebia Therapeutics, which has raised $88 million, and GuideCX, with $10 million in funding. Orchard Venture Partners also invested in Kereos, Logical Therapeutics, and Nymirum. The firm's investment strategy emphasizes scientific innovation and potential for significant growth in the life sciences sector.